249 related articles for article (PubMed ID: 18535019)
1. Fatigue, depression and progression in multiple sclerosis.
Koch M; Uyttenboogaart M; van Harten A; Heerings M; De Keyser J
Mult Scler; 2008 Jul; 14(6):815-22. PubMed ID: 18535019
[TBL] [Abstract][Full Text] [Related]
2. Natural history of multiple sclerosis: a unifying concept.
Confavreux C; Vukusic S
Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
[TBL] [Abstract][Full Text] [Related]
3. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the risk of secondary progression in multiple sclerosis.
Koch M; Uyttenboogaart M; van Harten A; De Keyser J
Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.
Lobentanz IS; Asenbaum S; Vass K; Sauter C; Klösch G; Kollegger H; Kristoferitsch W; Zeitlhofer J
Acta Neurol Scand; 2004 Jul; 110(1):6-13. PubMed ID: 15180801
[TBL] [Abstract][Full Text] [Related]
6. The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
Kobelt G; Texier-Richard B; Lindgren P
Mult Scler; 2009 Jun; 15(6):741-51. PubMed ID: 19383645
[TBL] [Abstract][Full Text] [Related]
7. Social anxiety in a multiple sclerosis clinic population.
Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
[TBL] [Abstract][Full Text] [Related]
8. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
Kragt JJ; Thompson AJ; Montalban X; Tintoré M; Río J; Polman CH; Uitdehaag BM
Neurology; 2008 Mar; 70(13 Pt 2):1084-91. PubMed ID: 18184917
[TBL] [Abstract][Full Text] [Related]
9. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
Sayao AL; Bueno AM; Devonshire V; Tremlett H;
Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
[TBL] [Abstract][Full Text] [Related]
10. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
[TBL] [Abstract][Full Text] [Related]
11. Progression in familial and nonfamilial MS.
Koch M; Uyttenboogaart M; Heerings M; Heersema D; Mostert J; De Keyser J
Mult Scler; 2008 Apr; 14(3):300-6. PubMed ID: 18208881
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
[TBL] [Abstract][Full Text] [Related]
13. Timing of birth and disease progression in multiple sclerosis.
Koch M; De Keyser J; Tremlett H
Mult Scler; 2008 Jul; 14(6):793-8. PubMed ID: 18573829
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
Zellini F; Niepel G; Tench CR; Constantinescu CS
Mult Scler; 2009 Dec; 15(12):1442-9. PubMed ID: 19995847
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
16. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
17. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
Morrow SA; Weinstock-Guttman B; Munschauer FE; Hojnacki D; Benedict RH
Mult Scler; 2009 Aug; 15(8):998-1005. PubMed ID: 19667024
[TBL] [Abstract][Full Text] [Related]
18. Cigarette smoking and progression in multiple sclerosis.
Koch M; van Harten A; Uyttenboogaart M; De Keyser J
Neurology; 2007 Oct; 69(15):1515-20. PubMed ID: 17923613
[TBL] [Abstract][Full Text] [Related]
19. Alexithymia in multiple sclerosis: relationship with fatigue and depression.
Bodini B; Mandarelli G; Tomassini V; Tarsitani L; Pestalozza I; Gasperini C; Lenzi GL; Pancheri P; Pozzilli C
Acta Neurol Scand; 2008 Jul; 118(1):18-23. PubMed ID: 18162056
[TBL] [Abstract][Full Text] [Related]
20. The natural history of primary progressive MS in British Columbia, Canada.
Tremlett H; Paty D; Devonshire V
Neurology; 2005 Dec; 65(12):1919-23. PubMed ID: 16380613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
